Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults.


Department of Surgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. Electronic address: [Email]


Neisseria meningitidis serogroup B is the most common form of meningococcal infection in young adults in the U.S. Vaccines have recently become available, but it is not clear that the benefits outweigh the costs. The purpose of this study was to assess cost effectiveness and determine potentially favorable conditions for universal vaccination.

OUR Recent Articles